PDS Biotechnology Corp PDSB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:57 PM EDT
3.63quote price arrow up+0.09 (+2.69%)
Volume
8,601
Close
3.54quote price arrow down-0.05 (-1.53%)
Volume
707,540
52 week range
2.59 - 10.27
Loading...
  • Open3.60
  • Day High3.77
  • Day Low3.48
  • Prev Close3.59
  • 52 Week High10.27
  • 52 Week High Date06/01/23
  • 52 Week Low2.59
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap129.661M
  • Shares Out36.68M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-28.87

KEY STATS

  • Open3.60
  • Day High3.77
  • Day Low3.48
  • Prev Close3.59
  • 52 Week High10.27
  • 52 Week High Date06/01/23
  • 52 Week Low2.59
  • 52 Week Low Date04/19/24
  • Market Cap129.661M
  • Shares Out36.68M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-28.87

RATIOS/PROFITABILITY

  • EPS (TTM)-1.39
  • P/E (TTM)-2.55
  • Fwd P/E (NTM)-2.38
  • EBITDA (TTM)-42.998M
  • ROE (TTM)-122.46%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)91.28%

EVENTS

  • Earnings Date05/15/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PDS Biotechnology Corp

 

Profile

MORE
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing...
Stephen Glover
Independent Chairman of the Board
Frank Bedu-Addo Ph.D.
President, Chief Executive Officer, Director
Stephan Toutain
Chief Operations Officer
Lars Boesgaard
Chief Financial Officer
Address
303A College Road East
Princeton, NJ
08540
United States

Top Peers

SYMBOLLASTCHG%CHG
CRVS
Corvus Pharmaceuticals Inc
2.26+0.15+7.11%
BCAB
Bioatla Inc
2.61-0.03-1.14%
CTXR
Citius Pharmaceuticals Inc
0.6876-0.0077-1.1074%
ACET
Adicet Bio Inc
1.33-0.11-7.64%
RZLT
Rezolute Inc
2.68-0.17-5.96%